GGrantIndex
Sort

130,381 grants matching hiv

Novel Therapeutics HIV-associated Cognitive Disorders

$1,288,239
Justin C McArthur · Johns Hopkins University · P30 · FY2010 · MH

HIV PREVENTION SERVICES, CAPACITY BUILDING ASSISTANCE AND EVALUATION ACTIVITIES F

$1,288,133
Harry Peter Hausler · Tb Hiv Care · U2G · FY2013 · GH

Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study

$1,287,792
Jeannette R Ickovics · Yale University · R01 · FY2010 · MH

Stellenbosch University Clinical Trials Unit (SUN-CTU)

$1,287,739
Mark Fredric Cotton · Stellenbosch University · UM1 · FY2017 · AI

Alcohol and HIV: Biobehavioral Interactions and Interventions

$1,287,649
Peter M. Monti · Brown University · P01 · FY2015 · AA

Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study

$1,287,430
Philip Todd Korthuis · Oregon Health & Science University · UH3 · FY2021 · DA

Optimizing HIV Care in Less Developed Countries

$1,287,063
Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2015 · AI

Role of co-receptor modified cells in HIV infection

$1,287,047
Carl H. June · University Of Pennsylvania · R01 · FY2012 · AI

Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies

$1,287,015
Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS

$1,286,888
Michael E Bird · National Native American Aids Prev Ctr · U65 · FY2008 · PS

Cardiovascular and HIV/AIDS Effects on Brain Structure/Function and Cognition

$1,286,627
James T. Becker · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AG

Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities

$1,286,550
Charles T Roberts · Oregon Health & Science University · R01 · FY2023 · DK

Post-acute metabolic sequelae of SARS-CoV-2 infection in nonhuman primates

$1,286,550
Charles T Roberts · Oregon Health & Science University · R01 · FY2022 · DK

Re-evaluating the Duration in Children of TB Treatment (REDUCE TB): A Phase 2 Duration Randomized Trial

$1,286,549
Anthony Joseph Garcia-Prats · University Of Wisconsin-Madison · U01 · FY2025 · AI

Center for AIDS Research

$1,286,536
Douglas D Richman · University Of California, San Diego · P30 · FY2012 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$1,286,403
Andrew Gans · New Mexico State Department Of Health · U62 · FY2015 · PS

Optimizing HIV Care in Less Developed Countries

$1,286,165
Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2017 · AI

HIV-1 SHEDDING FROM FEMALE GENITAL TRACT

$1,286,153
University Of Washington · P01 · FY2005 · HD

1) Core Surveillance, 2)HIV INCIDENCE SURVEILLANCE, 3)GEOCODING DATA, 4)MOLECULAR

$1,286,099
Susan Scheer · San Francisco Department Of Public Health · U62 · FY2014 · PS

WU-MDACC Inter-Institutional Molecular Imaging Center

$1,286,033
Samuel Achilefu · Washington University · P50 · FY2016 · CA

Comprehensive NeuroHIV Center

$1,286,025
Kamel Khalili · Temple Univ Of The Commonwealth · P30 · FY2024 · MH

SIMIAN VACCINE EVALUATION UNITS: Conduct Study P190

$1,286,013
Vicki Traina-Dorge · Tulane University Of Louisiana · N01 · FY2015 · AI

Structural Biology of Proteins Involved in Signal Transduction and Regulation of

$1,285,863
R Andrew Byrd · Basic Sciences · Z01 · FY2007 · CA

WIHS Data Management and Analysis Center(WDMAC)

$1,285,628
Johns Hopkins University · U01 · FY2003 · AI

Development of Dendrimer and Combination Microbicides

$1,285,606
Jeremy Paull · Starpharma, Ltd · U19 · FY2006 · AI